UBT251
A Research Study on How UBT251 Affects Levels of Midazolam, Caffeine and Warfarin in the Blood of Participants With Excess Body Weight
The United Bio-Technology (Hengqin) Co · Phase 1 · Recruiting · Enrollment 44
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| UBT251 | n/r | n/r | n/r | n/r |
| Cocktail (Warfarin/Caffeine/Midazolam) | n/r | n/r | n/r | n/r |
Not shown
- UBT251: endpoint not reported
- Cocktail (Warfarin/Caffeine/Midazolam): endpoint not reported